People | March 28, 2026
Shreehas Tambe appointed CEO & Managing Director of Biocon
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
It promises fewer injections for vision loss patients
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
Subscribe To Our Newsletter & Stay Updated
